Huntingtin is required for normal hematopoiesis

Human Molecular Genetics

Volumn 9, Issue 3, 2000, Pages 387-394

  Metzler, Martina ^a   Helgason, Cheryl D ^b   Dragatsis, Ioannis ^c   Zhang, Taiqi ^a   Gan, Lu ^a   Pineault, Nicolas ^b   Zeitlin, Scott O ^d   Humphries, R Keith ^b   Hayden, Michael R ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b BRITISH COLUMBIA CANCER AGENCY   (Canada)

^c Och Spine at New York Presbyterian Hospitals   (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

HUNTINGTIN; POLYGLUTAMINE;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CELL TYPE; EMBRYO DEVELOPMENT; FETUS; HEMATOPOIESIS; HUMAN; HUNTINGTON CHOREA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEM CELL;

EID: 0034639717     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/9.3.387     Document Type: Article

References (50)

1. Hayden, M.R. (1981) Huntington's Chorea. Springer-Verlag, London, Berlin, Heidelberg.
2. Harper, P.S. (1991) Huntington's Disease. W.B. Saunders, London, Philadelphia, PA.
3. Vonsattel, J.P., Myers, R.H., Stevens, T.J., Ferrante, R.J., Bird, E.D. and Richardson Jr, E.P. (1985) Neuropathological classification of Huntington's disease. J. Neuropathol. Exp. Neurol., 44, 559-577.
4. Portera-Cailliau, C., Hedreen, J.C., Price, D.L. and Koliatsos, V.E. (1995) Evidence for apoptotic cell death in Huntington disease and excitotoxic animal models. J. Neurosci., 15, 3775-3787.
5. Thomas, L.B., Gates, D.J., Richfield, E.K., O'Brien, T.F., Schweitzer, J.B. and Steindler, D.A. (1995) DNA end labeling (TUNEL) in Huntington's disease and other neuropathological conditions. Exp. Neurol., 133, 265-272.
6. Brandt, J., Bylsma, F.W., Gross, R., Stine, O.C., Ranen, N.G. and Ross, C.A. (1996) Trinucleotide repeat length and clinical progression in Huntington's disease. Neurology, 46, 527-531.
7. Nance, M.A. (1997) Clinical aspects of CAG repeat diseases. Brain Pathol., 7, 881-900.
8. Ross, C.A. (1995) When more is less: pathogenesis of glutamine repeat neurodegenerative diseases. Neuron, 15, 493-496.
9. Goldberg, Y.P., Nicholson, D.W., Rasper, D.M., Kalchman, M.A., Koide, H.B., Graham, R.K., Bromm, M., Kazemi-Esfarjani, P., Thornberry, N.A., Vaillancourt, J.P. et al. (1996) Cleavage of huntingtin by apopain, a proapoptotic cysteine protease, is modulated by the polyglutamine tract. Nature Genet., 13, 442-449.
10. Wellington, C.L., Ellerby, L.M., Hackam, A.S., Margolis, R.L., Trifiro, M.A., Singaraja, R., McCutcheon, K., Salvesen, G.S., Propp, S.S., Bromm, M. et al. (1998) Caspase cleavage of gene products associated with triplet expansion disorders generates truncated fragments containing the polyglutamine tract. J. Biol. Chem., 273, 9158-9167.
11. DiFiglia, M., Sapp, E., Chase, K.O., Davies, S.W., Bates, G.P., Vonsattel, J.P. and Aronin, N. (1997) Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science, 277, 1990-1993.
12. Hackam, A.S., Singaraja, R., Wellington, C.L., Metzler, M., McCutcheon, K., Zhang, T., Kalchman, M. and Hayden, M.R. (1998) The influence of huntingtin protein size on nuclear localization and cellular toxicity. J. Cell Biol., 141, 1097-1105.
13. Hodgson, J.G., Agopyan, N., Gutekunst, C.-A., Leavitt, B.R., LePaine, F., Singaraja, R., Smith, D.J., Bissada, N., McCutcheon, K., Nasir, J. et al. (1999) A YAC mouse model for Huntington's Disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration. Neuron, 23, 181-192.
14. Sanchez, I., Xu, C.-J., Juo, P., Kakizuka, A., Blenis, J. and Yuan, J. (1999) Caspase-8 is required for cell death induced by expanded polyglutamine repeats. Neuron, 22, 623-633.
15. Duyao, M.P., Auerbach, A.B., Ryan, A., Persichetti, F., Barnes, G.T., McNeil, S.M., Ge, P., Vonsattel, J.-P., Gusella, J.F., Joyner, A.L. et al. (1995) Inactivation of the mouse Huntington's disease gene homolog Hdh. Science, 269, 407-410.
16. Nasir, J., Floresco, S.B., O'Kusky, J.R., Diewert, V.M., Richman, J.M., Zeisler, J., Borowski, A., Marth, J.D., Phillips, A.G. and Hayden, M.R. (1995) Targeted disruption of the Huntington's disease gene results in embryonic lethality and behavioral and morphological changes in heterozygotes. Cell, 81, 811-823.
17. Zeitlin, S., Liu, J.-P., Chapman, D.L., Papaioannou, V.E. and Efstratiadis, A. (1995) Increased apoptosis and early embryonic lethality in mice nullizygous for the Huntington's disease gene homologue. Nature Genet., 11, 155-162.
18. Metzler, M., Chen, N., Helgason, C.D., Graham, R.K., Nichol, K., McCutcheon, K., Nasir, J., Humphries, R.K., Raymond, L.A. and Hayden, M.R. (1999) Life without huntingtin: normal differentiation into functional neurons. J. Neurochem., 72, 1009-1018.
19. White, J.K., Augood, S.J., Duyao, M.P., Vonsattel, J.-P., Gusella, J.F., Joyner, A.L. and MacDonald, M.E. (1997) Huntingtin is required for neurogenesis and is not impaired by the Huntington's disease CAG expansion. Nature Genet., 17, 404-410.
20. Kuida, K., Zheng, T.S., Na, S., Kuan, C., Yang, D., Karasuyama, H., Rakic, P. and Flavell, R.A. (1996) Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice. Nature, 384, 368-372.
21. DiFiglia, M., Sapp, E., Chase, K., Schwarz, C., Meloni, A., Young, C., Martin, E., Vonsattel, J.P., Carraway, R., Reeves, S.A. et al. (1995) Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons. Neuron, 14, 1075-1081.
22. Velier, J., Kim, M., Schwarz, C., Kim, T.-W., Sapp, E., Chase, K., Aronin, N. and DiFiglia, M. (1998) Wild-type and mutant huntingtins function in vesicle trafficking in the secretory and endocytic pathways. Exp. Neurol., 152, 34-40.
23. Li, X.J., Li, S.H., Sharp, A.H., Nucifora Jr. F.C., Schilling, G., Lanahan, A., Worley, P., Snyder, S.H. and Ross, C.A. (1995) A huntingtin-associated protein enriched in brain with implications for pathology. Nature, 378, 398-402.
24. Kalchman, M.A., Koide, H.B., McCutcheon, K., Graham, R.K., Nichol, K., Nishiyama, K., Lynn, F.C., Kazemi-Esfarjani, P., Wellington, C.L., Metzler, M. et al. (1997) HIP1, a human homolog of S. cerevisiae Sla2p, interacts with membrane-associated huntingtin in the brain. Nature Genet., 16, 44-53.
25. Wanker, E.E., Rovira, C., Scherzinger, E., Hasenbank, R., Walter, S., Tait, D., Colicelli, J. and Lehrach, H. (1997) HIP1: a huntingtin interacting protein isolated by the yeast two-hybrid system. Hum. Mol. Genet., 6, 487-495.
26. Sittler, A., Walter, S., Wedemeyer, N., Hasenbank, R., Scherzinger, E., Eickhoff, H., Bates, G.P., Lehrach, H. and Wanker, E.E. (1998) SH3GL3 associates with the huntingtin exon 1 protein and promotes the formation of polygln-containing protein aggregates. Mol. Cell, 2, 427-436.
27. Faber, P.W., Barnes, G.T., Srinidhi, J., Chen, J., Gusella, J.F. and MacDonald, M.E. (1998) Huntingtin interacts with a family of WW domain proteins. Hum. Mol. Genet., 7, 1463-1474.
28. Boutell, J.M., Thomas, P., Neal, J.W., Weston, V.J., Duce, J., Harper, P.S. and Jones, A.L. (1999) Aberrant interactions of transcriptional repressor proteins with the Huntington's disease gene product, huntingtin. Hum. Mol. Genet., 8, 1647-1655.
29. Ross, T.S., Bernard, O.A., Berger, R. and Gilliland, D.G. (1998) Fusion of huntingtin interacting protein 1 to Platelet-derived growth factor β receptor (PDGFβR) in chronic myelomonocytic leukemia with t(5;7)(q33;q11.2). Blood, 91, 4419-4426.
30. Sharp, A.H., Loev, S.J., Schilling, G., Li, S.-H., Li, X.-J., Bao, J., Wagster, M.V., Kotzuk, J.A., Steiner, J.P., Lo, A. et al. (1995) Widespread expression of Huntington's disease gene (IT15) protein product. Neuron, 14, 1065-1074.
31. Gutekunst, C.-A., Levey, A.I., Heilman, C.J., Whaley, W.L., Yi, H., Nash, N.R., Rees, H.D., Madden, J.J. and Hersch, S.M. (1995) Identification and localization of huntigtin in brain and human lymphoblastoid cell lines with anti-fusion protein antibodies. Proc. Natl Acad. Sci. USA, 92, 8710-8714.
32. Weiss, M.J., Keller, G. and Orkin, S.H. (1994) Novel insights into erythroid development revealed through in vitro differentiation of GATA-1-embryonic stem cells. Genes Dev., 8, 1184-1196.
33. Porcher, C., Swat, W., Rockwell, K., Fujiwara, Y., Alt, F.W. and Orkin, S.H. (1996) The T cell leukemia oncoprotein SCL/tal-1 is essential for development of all hematopoietic lineages. Cell, 86, 47-57.
34. Wiles, M.V. (1993) Methods in Enzymology. Academic Press, San Diego, CA.
35. Keller, G., Lacaud, G. and Robertson, S. (1999) Development of the hematopoietic system in the mouse. Exp. Hematol., 27, 777-787.
36. Dragatsis, I., Efstratiadis, A. and Zeitlin, S. (1998) Mouse mutant embryos lacking huntingtin are rescued from lethality by wild-type extraembryonic tissues. Development, 125, 1529-1539.
37. Young, P.E., Baumhueter, S. and Lasky, L.A. (1996) The Sialomucin CD34 is expressed on hematopoietic cells and blood vessels during murine development. Blood, 85, 96-105.
38. Helgason, C.D., Sauvageau, G., Lawrence, H.J., Largman, C. and Humphries, R.K. (1996) Overexpression of HOXB4 enhances the hematopoietic potential of embryonic stem cells differentiated in vitro. Blood, 87, 2740-2749.
39. + subpopulations of human bone marrow cells. Proc. Natl Acad. Sci. USA, 91, 12223-12227.
40. Kalchman, M.A., Graham, R.K., Xia, G., Koide, H.B., Hodgson, J.G., Graham, K.C., Goldberg, Y.P., Gietz, R.D., Pickart, C.M. and Hayden, M.R. (1996) Huntingtin is ubiquitinated and interacts with a specific ubiquitin conjugating enzyme. J. Biol. Chem., 271, 19385-19394.
41. Seki, N., Muramatsu, M., Sugano, S., Suzuki, S., Nakagawara, A., Ohhira, M., Hayashi, A., Hori, T. and Saito, T. (1998) Cloning, expression analysis, and chromosomal localization of HIP1R, an isolog of huntingtin interacting protein (HIP1). J. Hum. Genet., 6, 2205-2212.
42. Glued subunit of dynactin. Hum. Mol. Genet., 6, 2205-2212.
43. Glued. J. Neurosci., 18, 1261-1269.
44. Raths, S., Rohrer, J., Crausaz, F. and Riezman, H. (1993) end3 and end4: two mutants defective in receptor-mediated and fluid-phase endocytosis in Saccharomyces cerevisiae. J. Cell Biol., 120, 55-65.
45. Mulholland, J., Wesp, A., Riezman, H. and Botstein, D. (1997) Yeast actin cytoskeleton mutants accumulate a new class of golgi-derived secretory vesicle. Mol. Biol. Cell, 8, 1481-1499.
46. Givan, S.A. and Sprague Jr, G.F. (1997) The ankyrin repeat-containing protein Akr1p is required for the endocytosis of yeast pheromone receptors. Mol. Biol. Cell, 8, 1317-1327.
47. Hirst, J. and Robinson, M.S. (1998) Clathrin and adaptors. Biochim. Biophys. Acta, 1404, 173-193.
48. Nguyen, J.T., Turck, C.W., Cohen, F.E., Zuckermann, R.N. and Lim, W.A. (1998) Exploiting the basis of proline recognition by SH3 and WW domains: design of N-substituted inhibitors. Science, 282, 2088-2092.
49. Humphries, R.K., Eaves, A.C. and Eaves, C.J. (1981) Self-renewal of hematopoietic stem cells during mixed colony formation in vitro. Proc. Natl Acad. Sci. USA, 78, 3629-3633.
50. Lin, B., Nasir, J., MacDonald, H., Hutchinson, G.B., Graham, R.K., Rommens, J.M. and Hayden, M.R. (1994) Sequence of the murine Huntington disease gene: evidence for conservation, alternate splicing and polymorphism in a triplet (CCG) repeat. Hum. Mol. Genet., 3, 85-92.